HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant human PDCD5 protein enhances chemosensitivity of breast cancer in vitro and in vivo.

Abstract
Resistance to paclitaxel is common for treatment of breast cancer. Programmed cell death 5 (PDCD5) accelerates apoptosis in different cell types in response to various stimuli; moreover PDCD5 has been shown to be down-regulated in many tumors. In this study, protein levels of PDCD5 were found to be up-regulated in paclitaxel-treated MDA-MB-231 breast cancer cells. MTT, CCK-8, and clonogenic assays have shown that recombinant human PDCD5 (rhPDCD5) alone could not produce an obvious growth inhibition. However, upon paclitaxel triggering apoptosis, rhPDCD5 protein potentiated chemotherapeutic drugs-induced growth arrest in MDA-MB-231, SK-BR-3, and ZR-75-1 breast cancer cells. In vivo, we use a human breast cancer xenograft model to study. We found that rhPDCD5 dramatically improves the antitumor effects of paclitaxel treatment by intraperitoneal administration. These data suggest that rhPDCD5 has the potential to use as a therapeutic agent to enhance the paclitaxel sensitivity of breast cancer cells.
AuthorsLanlan Wang, Changjun Wang, Bingnan Su, Quansheng Song, Yingmei Zhang, Yang Luo, Qi Li, Weifeng Tan, Dalong Ma, Lu Wang
JournalBiochemistry and cell biology = Biochimie et biologie cellulaire (Biochem Cell Biol) Vol. 91 Issue 6 Pg. 526-31 (Dec 2013) ISSN: 1208-6002 [Electronic] Canada
PMID24219296 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Apoptosis Regulatory Proteins
  • Neoplasm Proteins
  • PDCD5 protein, human
  • Recombinant Proteins
  • Paclitaxel
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Apoptosis Regulatory Proteins (genetics, metabolism, pharmacology)
  • Breast Neoplasms (drug therapy, genetics, pathology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Drug Resistance, Neoplasm (drug effects)
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Humans
  • Injections, Intraperitoneal
  • Mice
  • Mice, Nude
  • Neoplasm Proteins (genetics, metabolism, pharmacology)
  • Paclitaxel (pharmacology)
  • Recombinant Proteins (genetics, metabolism, pharmacology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: